Glenn L. Stoller, M.D.

Chief Scientific Officer

Glenn L. Stoller, M.D., is a nationally recognized retina specialist, medical scientist and innovator. He has participated in all stages of preclinical and clinical development for therapeutics and devices as well as and post-approval sales and marketing. As a principal investigator, pharmaceutical industry consultant, and Scientific Advisory Board member, he has participated in over 40 clinical trials for ocular diseases including wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and retinal venous occlusive disease. Dr. Stoller led Lpath Ocular and oversaw the preclinical and clinical development of iSONEP, from inception through a development and commercialization partnership with Pfizer(NYSE:PFE – News). He led the non-GLP and IND enabling studies for iSONEP leveraging relationships with biotech companies, contract research organizations, and academia. He was actively involved in all aspects of the iSONEP ocular program, including formulation, toxicology and CMC. He played a key role in the design and development of clinical protocols and presentation of the program to the FDA. Dr. Stoller currently serves as a member of the Pfizer-Lpath Joint Development Committee.

Dr. Stoller played a key role in establishing that bioactive lipids are mediators of human retinal disease. He has published numerous articles and book chapters, and he has lectured extensively. He is a member of the major medical organizations in his field including The Retina Society and The American Society of Retina Specialists. He is currently a Steering Committee Member of the American Academy of Ophthalmology’s Ophthalmic Registry Work Group where he serves as the sole representative for The Macula Society, The Retina Society and The American Society of Retina Specialists. He has served as Editorial Board Member of The American Academy Of Ophthalmology.

Dr. Stoller graduated summa cum laude and Phi Beta Kappa from the University of Rochester with a degree in neuroscience. Dr. Stoller graduated Alpha Omega Alpha from NYU School of Medicine where he was awarded the Valentine Mott Medal for the medical student who has made the best contribution to clinical investigation in surgery. He completed his ophthalmology residency at the Harkness Eye Institute at Columbia University and a vitreoretinal fellowship at Weill Cornell Medical Center.

Dr. Stoller is a board certified ophthalmologist specializing in medical and surgical diseases of the retina, vitreous and macula and currently practices at Ophthalmic Consultants of Long Island in New York.